4//SEC Filing
Appelhans Dannielle 4
Accession 0001179110-22-000695
CIK 0001709401other
Filed
Jan 31, 7:00 PM ET
Accepted
Feb 1, 9:19 PM ET
Size
7.6 KB
Accession
0001179110-22-000695
Insider Transaction Report
Form 4
Appelhans Dannielle
Chief Operating Officer
Transactions
- Award
Stock Option (Right to Buy)
2022-01-31+125,000→ 125,000 totalExercise: $6.75Exp: 2032-01-30→ Common Stock (125,000 underlying) - Award
Restricted Stock Units
2022-01-31+30,000→ 30,000 total→ Common Stock (30,000 underlying)
Footnotes (3)
- [F1]25% of this option shall vest on January 31, 2023, then in 12 equal quarterly installments thereafter.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F3]The shares underlying the restricted stock units vest in four equal annual installments beginning on January 31, 2023.
Documents
Issuer
Rubius Therapeutics, Inc.
CIK 0001709401
Entity typeother
Related Parties
1- filerCIK 0001874962
Filing Metadata
- Form type
- 4
- Filed
- Jan 31, 7:00 PM ET
- Accepted
- Feb 1, 9:19 PM ET
- Size
- 7.6 KB